Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
05:13pm, Friday, 08'th Jul 2022
Jason Tauber, Neuberger Berman large cap disciplined growth and the disruptors portfolio manager, joins 'Closing Bell: Overtime' to discus his bullish case for the growth trade.
Radius (RDUS) Randomizes Patient in Prader-Willi Syndrome Study
03:40pm, Friday, 08'th Jul 2022 Zacks Investment Research
Radius (RDUS) randomizes the first patient in the SCOUT-015 study of pipeline candidate, RAD011, for Prader-Willi Syndrome.
Want $1 Million by Retirement? Here's How Much You Should Invest Today
01:08pm, Friday, 08'th Jul 2022 The Motley Fool
If you start early, you don't need to invest all that much to grow your portfolio to $1 million.
The direction of M&A in biotech is very, very vast, says Oppenheimer's Holz
03:24pm, Thursday, 07'th Jul 2022
Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the possibility of M&A in the healthcare sector, if investors remain focused on the oncology side of healthcare bus
This Analyst Cuts Price Target On Microsoft; Here's The Biggest Price Target Changes For Thursday
11:53am, Thursday, 07'th Jul 2022 Benzinga
Truist Securities cut Criteo S.A. (NASDAQ: CRTO) price target from $40 to $35. Criteo shares fell 3.5% to close at $22.92 on Wednesday.
Barclays raised Eli Lilly and Company (NYSE: LLY) price targ
Should Invesco Dynamic Large Cap Growth ETF (PWB) Be on Your Investing Radar?
10:20am, Thursday, 07'th Jul 2022 Zacks Investment Research
Style Box ETF report for PWB
As Markets Churn, These 2 Stocks Just Hit All-Time Highs
09:51pm, Wednesday, 06'th Jul 2022 The Motley Fool
You can find winners even in today's stock market.
As Markets Churn, These 2 Stocks Just Hit All-Time Highs
05:51pm, Wednesday, 06'th Jul 2022
You can find winners even in today's stock market.
Want to Retire Early? Buy and Hold These 2 Dividend Stocks for Decades
02:53pm, Wednesday, 06'th Jul 2022 The Motley Fool
These are safe stocks you can count on for recurring dividend income.
Biogen (BIIB) Lecanemab Gets FDA Priority Tag for Alzheimer's
01:15pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
The FDA sets a target date of Jan 6, 2023 for Biogen (BIIB) and partner Eisai's regulatory filing, which seeks accelerated approval for lecanemab to treat Alzheimer's disease (AD).
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
09:50pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Eli Lilly (LLY) closed the most recent trading day at $327.18, moving +0.76% from the previous trading session.
What Stocks To Buy Today? 5 Health Care Stocks To Know
04:30pm, Tuesday, 05'th Jul 2022
Could health care stocks be the best stocks to jump on in the second half of 2022?
3rd-Quarter Clinical Trial Data Could Shake Up Pharma Stocks
11:43am, Tuesday, 05'th Jul 2022
Health care investors would be wise to keep tabs on the results of numerous drug trials scheduled to be revealed in the third quarter. Trial data can impact the stock price of a pharmaceutical company
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
04:25pm, Monday, 04'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter
07:14pm, Friday, 01'st Jul 2022 MarketWatch
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.
